IMPACT OF FGF-23 ON THE EVOLUTION OF LEFT VENTRICULAR HYPERTROPHY IN INCIDENT DIALYSIS PATIENTS: A PROSPECTIVE STUDY

被引：0
|
作者：
Crowley, Lisa E. [1 ]
Pritchard, Corey [2 ]
Eldehni, Tarek [3 ]
Odudu, Aghogho [3 ]
Taal, Maarten [4 ]
McIntyre, Christopher W. [1 ]
Selby, Nicholas M. [3 ]
机构：
[1] London Hlth Sci Ctr, Kidney Clin Res Unit, London, ON, Canada
[2] Royal Derby Hosp, Clin Pathol, Derby, England
[3] Royal Derby Hosp, Renal Med, Derby, England
[4] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP495
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [41] Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)
    Gerdts, Eva
    Cramariuc, Dana
    de Simone, Giovanni
    Wachtell, Kristian
    Dahlof, Bjorn
    Devereux, Richard B.
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2008, 9 (06): : 809 - 815
  • [42] FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
    Alexander Grabner
    Karla Schramm
    Neerupma Silswal
    Matt Hendrix
    Christopher Yanucil
    Brian Czaya
    Saurav Singh
    Myles Wolf
    Sven Hermann
    Jörg Stypmann
    Giovana Seno Di Marco
    Marcus Brand
    Michael J. Wacker
    Christian Faul
    Scientific Reports, 7
  • [43] FGF23 Concentration is Associated With Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction in Cardiology Inpatients
    Shibata, Kensaku
    Morita, Hideaki
    Fujita, Shuichi
    Sohmiya, Koichi
    Hoshiga, Masaaki
    Ishizaka, Nobukazu
    CIRCULATION, 2013, 128 (22)
  • [44] FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
    Grabner, Alexander
    Schramm, Karla
    Silswal, Neerupma
    Hendrix, Matt
    Yanucil, Christopher
    Czaya, Brian
    Singh, Saurav
    Wolf, Myles
    Hermann, Sven
    Stypmann, Joerg
    Di Marco, Giovana Seno
    Brand, Marcus
    Wacker, Michael J.
    Faul, Christian
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients
    Sarmento-Dias, Margarida
    Santos-Araujo, Carla
    Poinhos, Rui
    Oliveira, Bruno
    Sousa, Maria Joao
    Silva, Liliana Simoes
    Silva, Isabel Soares
    Correia, Flora
    Pestana, Manuel
    CLINICAL NEPHROLOGY, 2016, 85 (03) : 135 - 141
  • [46] FGF-23 BLOOD LEVELS PREDICT PERITONEAL DAILY PHOSPHATE REMOVAL IN PATIENTS ON PERITONEAL DIALYSIS
    Sarmento-Dias, Margarida
    Santos-Araujo, Carla
    Poinhos, Rui
    Silva, Isabel Soares
    Silva, Liliana Simoes
    Sousa, Maria Joao
    Correia, Flora
    Pestana, Manuel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 224 - 224
  • [47] THE EFFECT OF VERAPAMIL ON DIALYSIS PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY
    WATSON, AJ
    WHELTON, PK
    GIMENEZ, LF
    FORTUIN, NJ
    JOURNAL OF HYPERTENSION, 1986, 4 : S303 - S305
  • [48] Sex Difference in the Prevalence of Left Ventricular Hypertrophy in Dialysis Patients
    Cheng, Li-Tao
    Gao, Yan-Li
    Tian, Jun-Ping
    Gu, Yue
    Zhang, Li
    Bi, Shu-Hong
    Tang, Wen
    Lindholm, Bengt
    Wang, Tao
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (05) : 398 - 405
  • [49] Predictors of Left Ventricular Hypertrophy and Their Cutoffs in Peritoneal Dialysis Patients
    Hassan, Kamal
    Hassan, Shadi
    Anwar, Saab
    Zaher, Armaly
    Edgem, Rabia
    Hassan, Fadi
    INTERNATIONAL HEART JOURNAL, 2015, 56 (02) : 186 - 191
  • [50] Gender differences in mediators of left ventricular hypertrophy in dialysis patients
    Savage, T
    Giles, M
    Tomson, CV
    Raine, AEG
    CLINICAL NEPHROLOGY, 1998, 49 (02) : 107 - 112
12345